Hideyuki Takedani

Tsuruga, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Five-Year Longitudinal Changes in Treatment Strategies and Clinical Outcomes in Adults With Haemophilia: The ADVANCE Japan Cohort Study.

Five-Year Longitudinal Changes in Treatment Strategies and Clinical Outcomes in Adults With Haemophilia: The ADVANCE Japan Cohort Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 15, 2026

Cardiovascular risk scores estimate arterial thrombotic risk in aging adults with hemophilia in the ADVANCE Japan cohort.

Cardiovascular risk scores estimate arterial thrombotic risk in aging adults with hemophilia in the ADVANCE Japan cohort.

Journal: Blood advances

Published: March 23, 2026

A cohort study on cardiovascular diseases in adults with hemophilia: an interim subanalysis on comorbidities and medication from ADVANCE Japan

A cohort study on cardiovascular diseases in adults with hemophilia: an interim subanalysis on comorbidities and medication from ADVANCE Japan

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

AOZORA study: 3-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis.

AOZORA study: 3-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis.

Journal: Research and practice in thrombosis and haemostasis

Published: April 07, 2025

Managing Haemophilic Arthropathy in People With Haemophilia in Japan: An Informal Consensus.

Managing Haemophilic Arthropathy in People With Haemophilia in Japan: An Informal Consensus.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 19, 2024

Artificial intelligence-assisted ultrasound imaging in hemophilia: research, development, and evaluation of hemarthrosis and synovitis detection.

Artificial intelligence-assisted ultrasound imaging in hemophilia: research, development, and evaluation of hemarthrosis and synovitis detection.

Journal: Research and practice in thrombosis and haemostasis

Published: April 08, 2024

Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study.

Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study.

Journal: Research and practice in thrombosis and haemostasis

Published: April 06, 2024

Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data.

Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 02, 2023

Plasma-derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors.

Plasma-derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 25, 2022

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.

Journal: Molecular therapy. Methods & clinical development

Published: June 21, 2022

AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.

AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.

Journal: BMJ open

Published: June 13, 2022

Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.

Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.

Journal: BMJ open

Published: February 18, 2022

Showing 1-12 of 49

Last Updated: 09/26/2026